Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bioadaptives Inc (BDPT)

Bioadaptives Inc (BDPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing

LAS VEGAS, Oct. 07, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT) today announced the commercial availability of MyndMedâ„¢ , a next-generation cognitive-support dietary supplement...

BDPT : 0.0281 (+27.73%)
BDPTD : 0.1089 (-1.00%)
BioAdaptives’ MyndMed™ Receives Full Clearance from TruShield™, Meeting UFC and WADA Standards for Athlete Safety

LAS VEGAS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives, Inc. (OTCMKTS: BDPT), a leader in natural health and performance supplements, today announced that its flagship nootropic formula,...

BDPT : 0.0281 (+27.73%)
BDPTD : 0.1089 (-1.00%)
BioAdaptives Announces National Launch of NeuroRush™ — A Cutting-Edge Adaptogenic Nootropic for Mental Clarity, Focus, and Resilience

LAS VEGAS, July 16, 2025 (GLOBE NEWSWIRE) -- BioAdaptives, Inc. (OTC: BDPT), an innovator in evidence-based wellness solutions, today announced the upcoming national release of NeuroRushâ„¢ , a next-generation...

BDPT : 0.0281 (+27.73%)
BDPTD : 0.1089 (-1.00%)
BioAdaptives Announces National Launch of Pawpaâ„¢ Regen

BDPT : 0.0281 (+27.73%)
BDPTD : 0.1089 (-1.00%)
BioAdaptives® PawPa™ Regen Provides Breakthrough Stem Cell Support for Pets, Backed by Clinically Proven APBAR® Scale Improvements

BDPT : 0.0281 (+27.73%)
BDPTD : 0.1089 (-1.00%)
Zeranovia(TM) Weight Loss Product Shows Promising Results in Dosage Trial

BDPT : 0.0281 (+27.73%)
BDPTD : 0.1089 (-1.00%)
BioAdaptives Welcomes UFC Senior Executive Reed Harris to Its Board of Advisors

BDPT : 0.0281 (+27.73%)
BDPTD : 0.1089 (-1.00%)
BioAdaptives Welcomes Mark Frissora, Acclaimed Business Leader, to Its Board of Directors

BDPT : 0.0281 (+27.73%)
BDPTD : 0.1089 (-1.00%)
Insider Purchase: Director at $BDPT (BDPT) Buys 125,000 Shares

Gimhana Sasanka Dissanayake, a director at $BDPT ($BDPT), bought 125,000 shares of the company on 11-22-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased...

BDPT : 0.0281 (+27.73%)
BioAdaptives, Inc. Announces 5 Unique Products Ready for Phased Entry Into the Nutritional Marketplace

BDPT : 0.0281 (+27.73%)

Barchart Exclusives

'Project Catalyst' Is Coming for This High-Yield Dividend Star. Should You Buy Shares in 2026 to Profit?
Can AI save this consumer packaged foods company from the relentless margin pressure? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar